Defective interfering particles (DIP) of equine herpesvirus 1 (EHV-1) inhibit standard virus replication and mediate persistent infection. The DIP genome is comprised of only three genes: UL3, UL4, and a hybrid gene composed of portions of the IR4 (EICP22) and UL5 (EICP27) genes. The hybrid gene is important for DIP interference, but the function(s) of the UL3 and UL4 genes are unknown. Here, we show that UL4 is an early gene activated solely by the immediate early protein. The UL4 protein (UL4P) was detected at 4 hours post-infection, was localized throughout the nucleus and cytoplasm, and was not present in purified virions. EHV-1 lacking UL4P expression was infectious and displayed cell tropism and pathogenic properties in the mouse model similar to those of parental and revertant viruses. Reporter assays demonstrated that the UL4P has a broad inhibitory function, suggesting a potential role in establishing and/or maintaining DIP-mediated persistent infection.
Introduction
Equine herpesvirus 1 (EHV-1), a member of the Alphaherpesvirinae subfamily, is a major pathogen of equines worldwide, resulting in severe respiratory, neurological, and abortigenic disease (Allen and Bryans, 1986; Mettenleiter et al., 2008; O'Callaghan and Osterrieder, 2008) . Viral replication requires the gene program to be regulated in a coordinated and temporal fashion, following a progression from immediate early (IE) to early (E) to late (L) gene expression (Caughman et al., 1985; Gray et al., 1987) . EHV-1 encodes six regulatory proteins that govern the viral gene program, five being important in promoter activation and one serving as a negative regulatory protein. The sole IE protein (IEP) transactivates early and some late EHV-1 gene promoters and is capable of trans-repressing its own promoter (Smith et al., 1992) . Early proteins IR4P and UL5P function synergistically with the IEP to enhance expression of early and late promoters (Albrecht et al., 2004; Holden et al., 1995; Kim et al., 1997; Zhao et al., 1995) . EICP0P is an early regulatory protein that independently serves as a potent and promis-cuous trans-activator of EHV-1 genes of all temporal classes (Bowles et al., 1997) . The late ETIF protein is a tegument protein responsible for activating expression of the sole IE gene (Lewis et al., 1993; Purewal et al., 1994) and is essential for secondary envelopment and virus egress (von Einem et al., 2006) . The early IR2 protein is a truncated form of the IE protein (Harty and O'Callaghan, 1991) and serves to down-regulate the expression from all classes of viral promoters (Kim et al., 2006) . Lastly, the EHV-1 unique IR3 gene encodes a transcript that is antisense to the IE mRNA (Holden et al., 1992) , is not translated to a detectable protein product (Ahn et al., 2007) , and functions to down-regulate expression of the IE gene (Ahn et al., 2010) .
Like many viruses (Huang and Baltimore, 1970) , EHV-1 passaged at high multiplicity will form defective interfering particles (DIP) that can mediate a state of persistent infection (Campbell et al., 1976; Dauenhauer et al., 1982; Ebner et al., 2008; Ebner and O'Callaghan, 2006) . Present within the DIP genome (~7.5 kbp; Fig. 1B ) are the origin of replication, cis elements for cleavage and packaging, and only three genes: UL3 and UL4 conserved perfectly from the left terminus of the standard genome (~155 kbp; Fig. 1A ) and a unique hybrid gene formed by a recombination event that joins portions of the IR4 and UL5 regulatory genes (Chen et al., 1996 (Chen et al., , 1999 Ebner and O'Callaghan, 2006) . The IR4/UL5 hybrid gene (Hyb) negatively affects expression of many viral genes during DIP-mediated persistent infection (Chen et al., 1999) . Recent studies demonstrated that the IR4 portion of the Hyb protein is important for mediating this negative regulation as well as interfering with standard virus replication (Ebner et al., 2008) .
To date, no function has been reported for the UL3 or UL4 genes during persistent or lytic infection. In the present study, we identify the UL4 gene as an early gene and demonstrate that the UL4 protein (UL4P) has a nuclear and cytoplasmic localization and is not a component of purified EHV-1 virions. A possible regulatory function of the UL4P was examined through transient transfection assays which revealed that the UL4P inhibited the expression of reporter genes under the control of EHV-1 promoters of all gene classes as well as the promoters of heterologous viruses and cell genes tested to date. In addition, the absence of the UL4P resulted in an increase in the amount of viral transcripts of all gene classes during infection. Studies with a mutant EHV-1 lacking UL4 expression showed that the UL4P was not essential for viral replication in cell culture or a pathogenic phenotype in the CBA mouse model.
Results
The UL4 gene belongs to the early class in the EHV-1 gene program A previous report described the location of the 5′ and 3′ termini of the UL4 mRNA in relation to a TATA box and polyadenylation signal, respectively (Harty et al., 1993) . We set out to characterize UL4 gene transcription and assign the UL4 gene to a temporal class in the EHV-1 gene program. Northern blot analysis with a nucleotide probe specific for the UL4 transcript first detected a~0.9 kb mRNA at 2 hour post-infection (hpi) which reached maximal expression levels by 7 hpi ( Fig. 2A) . These data suggest that UL4 is an early gene. Additionally, metabolic inhibitor studies demonstrated that the UL4 gene is not transcribed when protein synthesis is inhibited by cycloheximide (CHX; Fig. 2B ); whereas, IE Fig. 1 . Genomes of the standard EHV-1 and EHV-1 defective interfering particles. (A) Organization of the EHV-1 standard (STD) genome and location/orientation of the regulatory genes and genes conserved within the DIP genome. U L unique long region; U S unique short segment; IR inverted repeat segment. Numbers show size of viral proteins in amino acid residues. (B) DIP genome comprised of a 7.5 kbp repeat. CPS cleavage/packaging sequence, ORI origin of DNA replication; Hyb hybrid gene of IR4/UL5 sequences.
Fig. 2.
Characterizing UL4 as an early gene through metabolic inhibitor studies, northern blotting, and luciferase assays. (A) Northern blot analysis of RK13 cells infected with EHV-1 with a UL4 specific oligonucleotide indicates that UL4 is an early gene. (B) Metabolic inhibitors were used to confirm that UL4 is an early gene. Cycloheximide (CHX) and phosphonoacetic acid (PAA) were used to treat RK13 cells infected with EHV-1 to inhibit protein synthesis or viral DNA replication, respectively. RNA was isolated from treated (+) and untreated (−) cells at 4 hpi for CHX and 8 hpi for PAA, and northern blot analysis was performed using probes for the IE, early thymidine kinase (TK), and UL4 genes. (C and D) Luciferase reporter assays were performed to examine the activation of the UL4 promoter by EHV-1 regulatory proteins. RK13 cells seeded in 24-well plates were transfected with 1 pmol of the pUL4-Luc reporter plasmid and 0.5 pmol of the effector plasmids pSV-IE, pSV-UL5, pSV-EICP0, pCMV-IR4, pCMV-UL4, pCMV-ETIF and pSV-IR2; either individually (C) or in combination with the IEP (D). Luciferase activity was measured at 48-72 hours post-transfection. Error bars show standard deviation of triplicate assays. mRNA, as expected, is detected in the presence and absence of CHX. Furthermore, the UL4 transcript like that of the early thymidine kinase (TK) transcript was synthesized when viral DNA replication was inhibited by phosphonoacetic acid (PAA). These data confirm that UL4 belongs to the early gene class, a finding further supported by the absence of a TAATGARAT motif within the UL4 promoter. This motif is present within the promoters of immediate early genes of other alphaherpesviruses (Lewis et al., 1997; Misra et al., 1994; Moriuchi et al., 1995) , including the sole IE gene of EHV-1 (Elliott and O'Hare, 1995; Grundy et al., 1989) , and is the target sequence for binding by the viral α-trans-inducing factor (Elliott and O'Hare, 1995) . Furthermore, in the reporter assays employing the UL4 promoter region inserted upstream of a luciferase reporter gene, the EHV-1 α-trans-inducing factor (ETIF) failed to activate the UL4 promoter, whereas the IEP strongly trans-activated the UL4 promoter ( Fig. 2C ), confirming that UL4 is an early gene. Additional studies concerning the activation of the UL4 promoter by combinations of plasmids that express EHV-1 regulatory proteins indicated that the IEP alone trans-activated the UL4 promoter maximally, and that no synergistic activation occurred when the IEP was co-expressed with other EHV-1 regulatory proteins ( Fig. 2D ).
Characterization of the UL4 protein
To begin to characterize the UL4 protein, a rabbit polyclonal anti-UL4P specific antibody was generated (Materials and methods). To verify the specificity of the anti-UL4P antibody, RK13 cells were transfected with plasmids that express UL4P, UL4 fused to either the carboxy-or amino-terminus of the green fluorescent protein (GFP), or GFP alone or cells were infected with RacL11 EHV-1. Cell lysates were harvested and subjected to western blot analysis using the OC95 anti-UL4P antibody and a mouse monoclonal anti-GFP antibody. In the transfected cells, the anti-GFP antibody detected bands corresponding to GFP (26 kDa; Fig. 3A lane 2) , the GFP-UL4 fusion protein (46 kDa; Fig. 3A  lane 7) , and the UL4-GFP fusion protein (46 kDa; Fig. 3A lanes 5 and 6) . This anti-GFP antibody also detected GFP ( Fig. 3A lane 8) in lysates of cells infected with the BAC-derived RacL11 virus that expresses the GFP gene inserted during the generation of the BAC (Rudolph et al., 2002) . The anti-UL4P antibody detected a 23 kDa protein from cells transfected with UL4 expression plasmids ( Fig. 3B lanes 3 and 4) as well as from infected cell lysates ( Fig. 3B lane 8) . Additionally, the anti-UL4P antibody detected the UL4-GFP fusion protein ( Fig. 3B lanes 5 and 6) and the GFP-UL4 fusion protein ( Fig. 3B lane 7) . No bands were detected with the anti-UL4P antibody in mock transfected cells ( Fig. 3B lane 1) or cells transfected with the GFP expression plasmid ( Fig. 3B lane 2) . Thus, the OC95 antibody was highly specific for the UL4P and demonstrated very little cross reactivity with cellular proteins.
A time course experiment was completed to examine UL4 protein translation. Western blot analysis of lysates of infected RK13 cells with the purified rabbit anti-UL4P antibody revealed that the 23 kDa protein seemed to accumulate after 4 hpi ( Fig. 3C ). To determine whether the UL4 protein is a component of the EHV-1 virion, purified virus particles were prepared and subjected to western blot analyses. Nitrocellulose membranes were reacted with primary antibodies specific for the UL4P, glycoprotein D (gD), an envelope glycoprotein essential for EHV-1 replication (Csellner et al., 2000; Flowers and O'Callaghan, 1992; Frampton et al., 2005) , and the EHV-1 nonstructural UL31 protein, the major DNA binding protein (Lewis et al., 1995) . As shown in Fig. 3D , the preparation of virions was free of cellular protein contamination as demonstrated by the lack of the nonstructural UL31 protein in the virion preparation, whereas this protein was present in large amounts in lysates of infected cells. As a positive control, the anti-gD antibody reacted with viral protein present in both infected cell lysates and purified virions. In contrast, the anti-UL4P antibody reacted strongly only with infected cell lysates and failed to react with proteins in the purified virion preparation, indicating that the UL4P is not a component of the EHV-1 virion.
Utilizing the monospecific anti-UL4P antibody, immunofluorescence assays were completed to determine the cellular localization of the UL4 protein in RK13 cells transfected with plasmids expressing either the UL4 gene or the UL4-GFP fusion gene, or cells infected with EHV-1. Expression of the UL4 protein ( Fig. 4A ) or the UL4-GFP fusion protein ( Fig. 4B ) in the absence of other viral proteins resulted in a broad distribution of the UL4P within both the cytoplasm and nucleus of these cells. A similar fluorescent staining pattern was observed in cells infected with EHV-1 ( Fig. 4C ), suggesting that the 23 kDa UL4 protein localizes within both the nucleus and cytoplasm during infection. To verify the localization of the UL4 protein in both cellular compartments, RK13 cells were infected with EHV-1, and cell lysates were separated into cytoplasmic and nuclear fractions as described in the Materials and Methods. Western blot analysis of the proteins isolated from these cellular fractions confirmed that the UL4 protein was located within both the cytoplasm and nucleus (data not shown).
UL4P is an inhibitor of gene expression and antagonizes IEP trans-activation of EHV-1 promoters
Although known to be conserved perfectly within the genome of defective interfering particles (Baumann et al., 1984 (Baumann et al., , 1986 Ebner et al., 2008; Ebner and O'Callaghan, 2006) , no function has been reported for UL4. Herpes simplex virus 1 (HSV-1) UL55, the UL4P homolog, was demonstrated to inhibit transient gene expression when co-transfected into cells along with plasmids expressing the immediate early gene α27 as well as alpha genes α0 and α4 (Block et al., 1991) . Additionally, Yamada et al. (1998) characterized the UL55 protein of HSV-2 as a potential accessory protein in virion assembly and maturation and found it to co-localize with capsid protein ICP35 at the periphery of infected cell nuclei. To determine whether UL4P possesses any regulatory activity, luciferase reporter assays were performed. The reporter plasmid expressed the firefly luciferase gene under the control of various EHV-1 promoters, including the immediate early (IE), early promoters EICP0, thymidine kinase (TK), and IR2, and late promoters ETIF and glycoprotein K (gK).
Rabbit kidney cells were transfected with the various reporter plasmids along with the effector plasmids pSV-IE and/or pCMV-UL4, and luciferase activity was measured at 48-72 hours post-transfection. For the IE promoter, luciferase activity was inhibited by 77% in the presence of the UL4 protein ( Fig. 5A ). In a separate reporter assay employing the chloramphenicol acetyltransferase (CAT) gene under the control of the EHV-1 IE promoter, UL4 protein expression inhibited CAT activity by 87% (data not shown). UL4P expression decreased luciferase activity for the early EHV-1 TK and IR2 promoters 95% and 85%, respectively (Figs. 5C and D). In addition, luciferase activity driven by EHV-1 late promoters was negatively affected by the UL4P, such that in the case of the ETIF and gK promoters the inhibition reached levels of 78% and 98%, respectively (Figs. 5E and F). Conversely, when cells were transfected with the IE effector plasmid, luciferase activity was greatly increased for the early promoters and the ETIF promoter; whereas, the late gK promoter and the IE promoter were inhibited by expression of the IE protein, confirming our previous reports (Caughman et al., 1985; Harty and O'Callaghan, 1991; Kim et al., 1999; Smith et al., 1992 Smith et al., , 1994 . When the UL4 and IE expression plasmids were co-transfected into cells, the ability of the IEP to trans-activate the early EICP0, TK, IR2, and late ETIF promoters was diminished (Figs. 5B to E). IEP trans-activation of these four promoters was inhibited by 45% to 70%. The IEP has been shown to inhibit its own promoter (Harty and O'Callaghan, 1991; Smith et al., 1994) , and the coexpression of the UL4 and IE proteins further abrogated the luciferase activity driven by the IE promoter ( Fig. 5A ). These data suggest that the UL4 protein plays an inhibitory role in governing the expression of EHV-1 genes.
Given that the UL4P appeared to function across all gene classes, we next wanted to establish if the negative effect on reporter expression was specific for EHV-1 genes. In a similar reporter assay, luciferase activity was measured from reporter plasmids that used the simian vacuolating virus 40 (SV40) large T antigen promoter and the human cytomegalovirus (CMV) IE promoter. In the presence of UL4P, luciferase activity was decreased 90% from these heterologous viral promoters as well ( Fig. 6A ), indicating that UL4P inhibition is not virus specific. The inhibitory effect of the UL4P was not specific for the firefly luciferase reporter gene as similar levels of inhibition were obtained in assays that employed Fig. 4 . Localization of the UL4 protein in transfected and EHV-1 infected cells by immunofluorescence with purified anti-UL4P antibody. RK13 cells were transfected with either the (A) pCMV-UL4 or the (B) pUL4-GFP expression plasmid, or (C) were infected with RacL11 EHV-1. Cells were fixed with 4% paraformaldehyde at 48 hours post-transfection or at 12 hours post-infection and permeabilized with 0.2% Triton X100 in PBS. Panels A and C: purified anti-UL4P antibody was used as the primary antibody and an Alexa Fluor 488 goat anti-rabbit IgG was the secondary antibody. Panel B shows fluorescence due to GFP expression. Coverslips were mounted with a DAPI solution to stain nuclei (top photograph of each panel). Arrows in the upper panels indicate the nuclei of the cells of interest stained in the lower panels. the renilla gene as the reporter (data not shown). Lastly, a number of cellular promoters was tested to ascertain whether expression of the UL4 protein affects non-viral gene expression. To this end, expression of the UL4 protein was found to inhibit luciferase activity driven by the GAPDH, eIF4E, IFNβ, and HPRT cellular promoters by 44%, 86%, 75%, and 78%, respectively (Fig. 6B ). These decreases in luciferase activity were not attributable to cytotoxicity in the presence of the UL4 protein, as demonstrated by similar levels of cell viability in cells expressing the UL4P compared to nontransfected cells (data not shown). Taken together, the data presented in Figs. 5 and 6 indicate that the UL4 protein negatively affects gene expression, not only from viral promoters but cellular promoters as well.
UL4 is not required for EHV-1 lytic replication
After observing the inhibitory activity of the UL4 protein against a broad range of viral and cellular promoters, we wanted to examine if UL4 plays an essential role in EHV-1 lytic infection. It was hypothesized that deletion of the UL4 gene would increase the ability of the virus to replicate due to the absence of the additional inhibitory activity of the UL4P. To begin to address this hypothesis, a UL4-null EHV-1 was generated utilizing the galK bacterial artificial chromosome (BAC) technology (Rudolph et al., 2002; Warming et al., 2005) . Initially, the UL4 gene was replaced by the galK gene to create a UL4-deleted virus. The galK gene was then replaced with a mutant form of UL4 that contained a STOP codon at position 18 within the amino acid sequence (UL4aa18stop) or a wild-type UL4 to generate a revertant virus (ΔUL4R). Once the mutant and revertant BACs were generated, the gross genomic structure was examined by BamH I restriction enzyme digestion. Fig. 7A demonstrates that the process used for generating the mutant and revertant BACs did not result in any spurious recombination events or alterations in the overall genomic structure, as evidenced by similar digestion patterns of the parental RacL11, ΔUL4R, and UL4aa18stop BACs. The second BamH I fragment in the ΔUL4 (galK + ) BAC migrated in agarose gels more slowly than the other BACs, indicative of the additional base pairs within the galK gene compared to the UL4 Fig. 5 . Luciferase assays examining the effect of the UL4 protein on luciferase expression driven by EHV-1 promoters of all gene classes. RK13 cells in 24-well plates were transfected with 0.5 pmol of the expression plasmids pCMV-UL4, pSV-IE, or both plasmids, along with 1 pmol of the luciferase reporter plasmid under the control of the EHV-1 (A) immediate early promoter; or early promoters (B) EICP0, (C) thymidine kinase (TK), and (D) IR2, or late promoters (E) ETIF and (F) glycoprotein K (gK). Luciferase activity was assayed at 48 hours post-transfection as described in Materials and methods. gene (Fig. 7A; lane 2) . Southern blot analysis for the presence of the UL4 gene within the various BACs revealed that the UL4 sequence was absent from the ΔUL4 (galK + ) BAC, while the UL4-specific probe hybridized to DNA sequences within the parent, mutant, and revertant BACs (Fig. 7B ). Furthermore, PCR analysis and DNA sequencing verified that the BACs were correct (data not shown).
To determine whether UL4 was essential for EHV-1 replication, the BACs were transfected into permissive RK13 cells. As shown in Fig. 8A , each BAC resulted in the formation of plaques in transfected cells, indicating that UL4 is dispensable for EHV-1 lytic replication. However, it was observed that the plaques formed by the UL4aa18stop virus were smaller in size compared to those of the parent and revertant viruses, being approximately one-third the size of wild-type and revertant plaques ( Fig. 8B ). To verify that the stop mutant virus did not produce UL4 protein, lysates from cells infected with the wild-type, mutant, and revertant viruses were subjected to western blot analysis. As expected, the UL4 protein was detected in cells infected with the wild-type RacL11 and ΔUL4R viruses, but not in cells infected with the UL4aa18stop virus ( Fig. 7C) . These data indicated that the UL4 protein is not essential for EHV-1 replication, but the smaller plaque size of the UL4aa18stop virus may indicate a deficiency in its ability to replicate or spread efficiently.
Single-step growth kinetics experiments performed to address this possibility revealed that the UL4aa18stop mutant replicated with similar kinetics and to equivalent levels as the wild-type and revertant viruses that express UL4 (Fig. 9A) . Similar virus titers were obtained from the extracellular supernatant of RK13 cells infected with all three viruses, indicating that impairment of virion release is not responsible for the smaller plaque phenotype. Finally, cell tropism was examined to determine whether UL4P plays a role in expanding the host range of EHV-1, as shown for the EHV-1 early IR4 regulatory gene (Breitenbach et al., 2009) as well as for the IR4 homologue EICP22 of HSV-1 (Poffenberger et al., 1993; Post and Roizman, 1981 ). The UL4aa18stop virus was able to replicate in cells of mouse, rabbit, equine, monkey, and human origin (Fig. 9B ). Virus titers in cells infected with all three viruses were similar, with exceptions of mouse L-M and human HeLa cells, for which an approximately one log reduction in maximal virus titer was observed for the UL4aa18stop mutant virus, indicating that UL4 does not contribute to the broad host range of EHV-1 (O'Callaghan and Osterrieder, 2008) . However, upon detailed statistical analysis of the viral titers from multiple experiments, we found that the values were significantly different between wild-type and the UL4aa18stop EHV-1 for all cell types. Although the levels of maximal virus production were statistically different, the biological relevance is not likely to be consequential.
The UL4 gene is not a virulence factor in the CBA mouse model of EHV-1 pathogenesis Although no striking differences were observed between the UL4-mutant virus and the parental EHV-1 in their abilities to infect and replicate in cell culture, we wanted to determine whether the UL4 gene plays a role in EHV-1 pathogenesis. Utilizing the well characterized CBA mouse model of EHV-1 infection (Colle et al., 1996; Frampton et al., 2002 Frampton et al., , 2004 Matsumura et al., 1996; O'Callaghan and Osterrieder, 2008; Smith et al., 2000 Smith et al., , 2005 , groups of 12 female mice were intranasally inoculated with wild-type, UL4aa18stop, or ΔUL4R viruses as well as with sterile medium for . Generation and verification of the UL4aa18stop EHV-1 and ΔUL4R revertant EHV-1 by galK BAC technology. Homologous recombination was used to delete the UL4 gene as described in Materials and methods. Briefly, PCR was utilized to append UL4 DNA flanking sequences to the galK gene. SW106 E. coli harboring the EHV-1 BAC were transformed with the resultant PCR product and plated on positive selection plates. To generate the revertant BAC, wild-type UL4 sequences were transformed into bacteria containing the mutant BAC and plated on negative selection plates with 2deoxygalactose. The mutant and revertant BAC genomes were analyzed and verified by (A) BamH I restriction enzyme digestion and (B) Southern blot analysis. (C) RK13 cells were transfected with each of the three BAC genomes to generate wild-type, UL4aa18stop, and ΔUL4R viruses. RK13 cells were then infected with each virus, and at 9 hours post-infection lysates were prepared and subjected to western blot analysis with the purified anti-UL4P antibody. a control group, and monitored for signs of morbidity and mortality over the course of 9 days. As expected, mice in the sterile medium group demonstrated no signs of infection and exhibited increases in body weight (Fig. 10A ). On the other hand, all mice infected with each of the three EHV-1 displayed ruffled fur and a huddling phenotype, along with significant decreases in overall body weight (Fig. 10A ). EHV-1 lacking UL4 gene expression caused decreases in body weight similar to that of the wild-type highly pathogenic EHV-1, suggesting that UL4 is not required for EHV-1 pathogenesis in the mouse. Furthermore, mortality rates were similar for mice infected with either the wild-type virus or the UL4aa18stop EHV-1 (Fig. 10B) . In cell culture, there was an approximate one log decrease in the ability of the UL4aa18stop mutant virus to replicate in mouse L-M cells compared to the parental virus ( Fig. 9B ). To determine whether the reduced ability of the UL4-mutant virus to replicate in mouse cells in culture was likewise reflected in vivo, infected mice were sacrificed at days 2, 3, and 4 post-infection, and virus was titered from infected lungs. As shown in Fig. 10C , the UL4aa18stop virus replicated as efficiently as the wild-type EHV-1 in murine lungs. Taken together, the results from these animal experiments indicate that the UL4 gene is not a determinant of virulence for EHV-1.
Viral transcripts of all gene classes are increased in the absence of UL4 protein synthesis
We previously observed that the UL4P was capable of inhibiting luciferase gene expression driven by representative EHV-1 promoters from all three gene classes (Fig. 5 ). To extend these findings, the effect of UL4P on the synthesis of EHV-1 transcripts was addressed. Cells were infected with wild-type virus or the UL4aa18stop EHV-1 and examined for the effect of the absence of the UL4 protein synthesis on the level of selected IE, E, and L transcripts. RNA was isolated and analyzed by northern blot assays at 4 hpi for IE, 8 hpi for early TK, and 12 hpi for late gK gene expression. As shown in Fig. 11 , the levels of Fig. 8 . Morphology of plaques produced on RK13 cells transfected with the parent, UL4aa18stop, and ΔUL4R BACs. (A) RK13 cells were transfected with the various BACs, overlaid with medium containing 1.5% methylcellulose, and examined after 5 days for plaque formation by staining with 0.5% methylene blue dye. (B) Plaque size was analyzed with the ImageJ software (Materials and Methods). 30 plaques produced by each virus were measured and the Student's-t test was used for statistical analysis. Fig. 9 . Growth kinetics and cell tropism of the wild-type EHV-1, UL4aa18stop EHV-1 and ΔUL4R EHV-1. (A) RK13 cells in 60-mm dishes were infected with the wild-type, mutant, and revertant viruses at an MOI of 5. Virus was harvested from the extracellular supernatant as well as from freeze-thawed cells at the indicated times post-infection and enumerated by plaque assay. (B) The ability of the wild-type, mutant, and revertant viruses to replicate in various cell types was determined by infecting mouse L-M, rabbit RK13, equine NBL-6, African green monkey Vero, and human HeLa cells at a MOI of 5. Maximal viral titers at 72 hours post-infection were determined by plaque assay on RK13 cells. the transcripts for each of the three viral genes were greater in the absence of the UL4 protein as compared to those of WT infected cells. Densitometry measurements revealed that the levels of the IE, TK, and gK transcripts were increased a minimum of 20% in the absence of the UL4P, and in repeated experiments these increases were as great as 42%. These data indicate that the absence of the UL4P allows for increased viral transcription at all times during infection, and that the UL4P is indeed an inhibitor of EHV-1 gene expression.
Discussion
The EHV-1 UL4 gene, conserved within the genome of defective interfering particles, has no attributed function during lytic replication or DIP-mediated persistent infection (Baumann et al., 1984 (Baumann et al., , 1986 Ebner et al., 2008; Ebner and O'Callaghan, 2006) . In this report, we presented findings suggesting that this early gene encodes an inhibitory protein that negatively affects viral and cellular gene expression. The expression of the UL4 protein was capable of inhibiting gene expression driven by promoters from all EHV-1 gene classes by greater than 75%. These data appear very similar to the results from experiments concerning the IR2 protein, a negative regulatory protein that was demonstrated to downregulate all EHV-1 gene promoters tested to date (Kim et al., 2006) . Comparing the broad negative regulatory activity of the IR2P and UL4P suggests that UL4P may serve as an auxiliary inhibitory protein to govern EHV-1 gene expression during lytic infection. However, this inhibitory function appears to differ from that reported for the HSV-1 UL55 protein (Block et al., 1991) , which shares only 32% amino acid identity with UL4P. In that report, the authors concluded that the inhibition of transient gene expression relied on the presence of other alpha genes expressed in conjunction with the UL55 protein, such that the UL55 protein alone was not sufficient to negatively affect viral gene expression. Conversely, in the case of the UL4 protein, EHV-1 gene expression was significantly inhibited when only the UL4P was expressed. Although these homologs may have an inhibitory function in common, our findings suggest that their mechanism of action is different. However, we cannot rule out the possibility that in the prior study involving HSV-1 UL55, alpha genes were required solely for the efficient expression of the UL55 gene. In that case, the alpha genes per se contributed no inhibitory function, and thus it is conceivable that UL4 and UL55 proteins function through a similar mechanism. We are interested in exploring how the UL4 protein functions to inhibit gene expression, and current work is focused on elucidating a mechanism. Due to the broad inhibitory activity of the UL4P, it appears that the mechanism is not genespecific as supported by the fact that the UL4P does not bind to specific promoter DNA sequences (data not shown). We have considered the possibility that the UL4 protein interacts with another protein involved in gene expression. GST-pulldown assays are being utilized to examine protein-protein interactions that may occur between UL4P and other viral and/or cellular proteins. In preliminary studies, the UL4 protein did not interact with the IEP; however, it appears that the UL4P functions at the level of gene transcription via an interaction with general transcription factors (unpublished data).
To determine whether the inhibitory function of UL4P was important for viral replication, a mutant virus (UL4aa18stop) was generated. Surprisingly, we found that the replication kinetics, cell tropism, and pathogenesis of an EHV-1 lacking UL4 expression were similar to those of the parental and UL4 revertant viruses (Figs. 9 and 10). These findings were contrary to our hypothesis that removing UL4 gene expression would allow enhanced growth of the mutant virus compared to wild-type EHV-1. As UL4 is not a diploid gene, serial passage of the UL4aa18stop EHV-1 was not expected to result in its reversion to a wild-type phenotype. Indeed, the UL4aa18stop virus failed to produce the UL4 protein upon serial Fig. 10 . Comparison of the pathogenic properties of wild-type, UL4-mutant and revertant EHV-1 in the CBA mouse model. Groups (n= 12 mice) of 6 week old female CBA mice were mock infected with sterile medium or were infected intranasally with 1.25 × 10 6 pfu of wild-type RacL11, UL4aa18stop, or ΔUL4R EHV-1. Mice were monitored daily for clinical signs of infection, gain or loss in body weight, and morbidity. (A) Changes in body weight; (B) Percent survival; and (C) Virus lung titer. Whole lungs were harvested from mice sacrificed on days 2, 3 and 4 post-infection, and virus was titered by plaque assay. Fig. 11 . Northern blot analysis examining gene expression in cells infected with wildtype (WT) or STOP-mutant EHV-1. RK13 cells were infected with wild-type EHV-1 or the UL4aa18stop EHV-1, and RNA was isolated at 4, 8, and 12 hours post-infection. Northern blot analysis was used to determine transcript levels for the immediate early (IE) gene, the early thymidine kinase (TK) gene, and the late glycoprotein K (gK) gene. passage in cell culture (data not shown). The varicella-zoster virus (VZV) ORF3 protein is a UL4P counterpart that has 37% identity in amino acid sequence. Similar to these findings with the UL4-mutant EHV-1, it was shown that deletion of VZV ORF3 did not affect virus replication in vivo or in vitro (Zhang et al., 2007) . One significant difference between the UL4aa18stop EHV-1 and the parental virus was a reduction in plaque size (Fig. 8) . One possible explanation for the smaller plaques is that the virus has a defect in the ability to egress from infected cells, but that possibility was not supported by the observation that the extracellular virus titers were identical for RK13 cells infected with the parental virus and the UL4aa18stop virus.
During DIP-mediated persistent infection, it is believed that the highly expressed IR4/UL5 hybrid protein is responsible for mediating the interference of standard virus replication, as demonstrated by the observation that recombinant DI particles deleted of the UL3 and UL4 genes and engineered to express only the hybrid protein retained DIP interference activity (Ebner et al., 2008) . However, it remains unclear what actually triggers the establishment of persistent infection and how high levels of DIP maintain persistent infection. Here, we presented data that demonstrate that the UL4 protein negatively affects all EHV-1 gene classes. As this gene is conserved perfectly within the DIP genome and expressed at very high levels in persistently infected cells (Gray et al., 1989) , it is possible the UL4 protein could greatly impair the expression of standard viral genes. This possibility is supported, in part, by the finding that EHV-1 gene expression is tempered in cells infected with the wild-type virus that expresses UL4P, as compared to gene expression in cells infected with the UL4aa18stop mutant EHV-1. This broad inhibitory activity may facilitate the establishment and/or maintenance of DIP-mediated persistent infection. As attractive as this may be, the studies to determine the role UL4 plays during persistency will require a better understanding of the function(s) mediated by this early gene product.
These studies are the first to characterize UL4 as a member of the early class within the EHV-1 gene program. The UL4 protein localizes within both the nucleus and cytoplasm of infected cells, but is not a component of mature virus particles. The luciferase reporter assays demonstrated that the UL4P is an inhibitory protein, a finding that was supported by the results of the viral gene expression studies using the UL4aa18stop EHV-1. Thus, the UL4 protein joins the IR2P as the second EHV-1 early gene product that possess predominantly negative activity. Current studies are addressing how this protein mediates this inhibitory outcome in the case of EHV-1 genes and if this mechanism applies to genes of heterologous viruses and host cells.
Materials and methods

Cell culture and virus propagation
Mouse L-M, rabbit RK13, equine NBL-6, African green monkey Vero and human HeLa cells were grown in Dulbecco's minimum essential medium (DMEM) supplemented with either 5% or 10% fetal bovine serum at 37°C in a 5% CO 2 incubator. The pathogenic EHV-1 strain RacL11 was propagated in equine NBL-6 cells, while the attenuated KyA strain was grown in mouse L-M cells. After growing a high-titer stock of KyA virus, the supernatant virus was collected and clarified by removing cells by centrifugation. Highly purified virions were prepared as previously described in detail (O'Callaghan and Randall, 1976; Perdue et al., 1974) .
Plasmids
Manipulation and cloning of the expression plasmids were performed according to the procedures described by Sambrook et al. (1989) . pGEX-UL4, which expresses the UL4 gene as a GST fusion protein, was generated by PCR amplifying the UL4 gene from the RacL11 BAC (Rudolph et al., 2002) to include the restriction enzyme sites EcoR I and Sal I with forward primer: 5′-CATGAATTCC-CATGCTGCCGGCAAACCGCGCAGAACAC-3′ and reverse primer: 5′-CTAGGTCGACTTATCGTTTATTTTCTCGCTGGCGCTCTTTGGCCGA-3′. The PCR product and the pGEX-4T-2 plasmid were digested with the appropriate enzymes and ligated. pGFP-UL4 expresses a GFP-UL4 fusion protein and was generated by PCR using forward primer: 5′-CATGTGTACAAGATGCTGCCGGCAAACCGCGCAGAA-3′ and reverse primer: 5′-CATTGCGGCCGCTTATCGTTTATTTTCTCGCTG-3′ to append restriction enzyme sites BsrG I and Not I, respectively, to the UL4 gene. The digested insert was cloned into the pEGFP-N1 plasmid that contains the enhanced GFP gene under the control of the HCMV IE promoter. The pUL4-GFP plasmid expresses an amino-terminal UL4-GFPfusion protein.PCR wasused to attach EcoR I and BamHIenzyme sites to the UL4 gene using forward primer: 5′-AATTGAATTCCGCCAC-CATGCTGCCGGCAAACCGCGCAGAAC-3′ and reverse primer: 5′-CATGG-GATCCCGTTTATTTTCTCGCTGGCGCTCTTTG-3′, respectively. The digested fragment was again inserted into the pEGFP-N1 plasmid. To generate pCMV-UL4, an expression plasmid that expresses the UL4 gene under the control of the HCMV IE promoter, forward primer: 5′-AATTGAATTCCGCCACCATGCTGCCGGCAAACCGCGCA-GAAC-3′ and reverse primer: 5′-CATTGCGGCCGCTTATCGTT-TATTTTCTCGCTG-3′ were used to add the EcoR I and Not I sites to the UL4 gene, respectively. The digested insert was then cloned into .1pt?>the pEGFP-N1 plasmid to replace the GFP gene. pUL4-Luc, a reporter plasmid that contains the firefly luciferase gene driven by the UL4 promoter, was created using PCR to attach Kpn I and Bgl II restriction sites flanking the UL4 promoter region. Forward primer: 5′-CATGGTACCCCAACGCAAACAGTTGGCACCGTG-3′ and reverse primer: 5′-CATAGATCTCAGGCTGGGAATTTGCTCGACTGAAG-3′ were used. The resulting 1.5 kb enzyme fragment encompassing the UL4 promoter with TATA box was inserted into the pGL3-Basic plasmid. The remaining expression and reporter plasmids were generated elsewhere (Bowles et al., 2000; Holden et al., 1995; Kim and O'Callaghan, 2001; Smith et al., 1992; Zhao et al., 1995) .
Expression and purification of GST-UL4 fusion protein
The induction of GST fusion protein synthesis and its purification have been described previously (Albrecht et al., 2004; Jang et al., 2001) . To prepare a purified UL4 protein lacking the GST moiety, GST-UL4 was treated with a thrombin cleavage capture kit (Novagen, Madison, WI) per the manufacturer's instructions, and the GST portion was removed using GST-bind resin beads (Novagen). The purified protein was concentrated using Amicon Ultra centrifugation filter devices with a size exclusion of 10 and 30 kDa (Millipore, Billerica, MA).
Generation of anti-UL4 protein polyclonal antibody
Antibody generation has been described elsewhere (Albrecht et al., 2004) . Briefly, two New Zealand White rabbits (approximately 4 kg per rabbit) were immunized with either the GST-UL4 fusion protein (OC94) or the purified UL4 protein (OC95). The primary inoculum was emulsified in Freund's complete adjuvant, and after 4-8 weeks, booster immunizations emulsified in incomplete Freund's adjuvant were administered every 14 days for a total of five booster injections for each rabbit. Before each booster injection, small quantities of serum were drawn from each rabbit to test antibody titers before the final bleed was performed. The anti-UL4P antibody was purified using protein A agarose beads (Pierce, Rockford, IL) according to the manufacturer's directions. The working dilution in western blot assays was 1:5000 or greater.
Immunofluorescence microscopy and cell fractionation RK13 cells were seeded onto No. 1.5 glass coverslips (Fischer Scientific, Pittsburgh, PA) in the bottom of a 6-well plate. The cells were either infected with wild-type RacL11 EHV-1 or transfected with the expression plasmids pCMV-UL4 or pUL4-GFP. Infected cells were fixed at 12 hours post-infection, while transfected cells were fixed at 48 hours post-transfection. Cells were fixed with a 4% paraformaldehyde solution in PBS, and cellular membranes were permeabilized with 0.2% Triton X100 in PBS. After washing the cells with PBS, 10% goat serum in PBS was used to block non-specific antibody interactions. Anti-UL4P OC95 antiserum was used as the primary antibody at a dilution of 1:100 in PBS/0.1% Tween-20 and the secondary antibody was Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen, Carlsbad, CA) at 1:100 in PBS/0.1% Tween-20. Unbound antibody was removed by washing, and the coverslips were removed from the 6-well plates and placed on glass slides. SlowFade Gold antifade reagent with DAPI (Invitrogen) was used as the mounting solution (arrows indicate nuclei in Fig. 4 ). Clear nail polish sealed the edges of the coverslips, and the slides were viewed on a Nikon Eclipse TE300 inverted fluorescent microscope (Melville, NY). Cells were separated into cytoplasmic and nuclear fractions by the following procedure, modified from Muramatsu et al. (1963) . Cells were washed with cold PBS, then scraped and pelletted in a microfuge tube. Resuspend pellets in ice-cold Buffer A (10 mM HEPES, pH 7.9; 1.5 mM MgCl 2 ; 10 mM KCl; 0.5 mM DTT) and keep on ice for 5 min. Cells were disrupted by repeated passage through a 26 gage needle. Disrupted cells were centrifuged at 300 g for 5 min at 4°C to pellet the nuclei. The supernatant was saved as the cytoplasmic fraction. The nuclear pellet was resuspended in sucrose buffer A (0.25 M sucrose, 10 mM MgCl 2 ), layered over a cushion of sucrose buffer B (0.88 M sucrose, 0.5 mM MgCl 2 ), and centrifuged at 3000 g for 10 min at 4°C. Nuclear pellets were disrupted with RIPA buffer (50 mM Tris, pH 7.5; 150 mM NaCl; 1% NP-40; 0.5% deoxycholate) and centrifuged at 3000 g for 10 min at 4°C to pellet insoluble debris.
Luciferase reporter assays
RK13 cells were seeded into 24-well plates and used the subsequent day at a confluency of 80%. Cells were transfected using lipofectin (Invitrogen) and Opti-MEM medium (Gibco, BRL, Carlsbad, CA) as detailed elsewhere (Ahn et al., 2007) . Briefly, 1 pmol of the various reporter plasmids and 0.5 pmol of the expression plasmids were co-transfected into RK13 cells. Eight hours later, regular growth medium was added, and luciferase activity was assayed at 48-72 hours post-transfection utilizing a luciferase assay kit (Promega, Madison, WI) and a POLARstar OPTIMA plate reader (BMG LABTECH Inc., Cary, NC) following the manufacturer's instructions.
Generation and confirmation of UL4-null EHV-1
A RacL11 BAC deleted for the UL4 gene was generated through galK BAC recombineering (Ahn et al., 2010; Warming et al., 2005) . To replace the UL4 gene, PCR amplification (forward primer: 5′-TTATCGTTTATTTTCTCGCTGGCGCTCTTTGGCCGAGGTTATTCCCC-TAGCCTGTTGACAATTAATCATCGGCA-3′ and reverse primer: 5′-ATGCTGCCGGCAAACCGCGCAGAACACTCATCTGATGCAGAGCCGCGG-GATCAGCACTGTCCTGCTCCTT-3′) was used to append UL4 flanking sequences to the ends of the galK selection gene, and the subsequent PCR product was transformed into SW106 E. coli harboring the RacL11 BAC. Bacteria were plated onto positive selection agar plates containing galactose, and colonies were screened by PCR (5′-CAGACCCA-GAGCTCCACGCACCGTCC-3′/5′-GCAGATCTTGCTCCCAGACCTGACC-3′ and 5′-CCCTCTTCTCGAACACGCCGATGAAAAAGGCG-3′/5′-GGCAGA-TACCTGCAGCCTTGTATCGGCC-3′) for the correct junction sequences. The galK marker was replaced with a mutant form of the UL4 gene that contains a STOP codon at position 18 (underlined; UL4aa18stop) or a wild-type form of the UL4 gene to generate a UL4 revertant BAC (ΔUL4R). PCR was used to create the desired DNA fragments that were transformed into the E. coli harboring the galK inserted RacL11 BAC (5′-TTATCGTTTATTTTCTCGCTGGCGC-3′/
′ -A T G C T G C C G G C A A A C C G C G C A G A A C A C T C A T C T G A T G C A -
GAGCCGCGGGATTAAATAGGCTCCCACGGGAGGA-3′ and 5′-TTATCGTTTATTTTCTCGCTGGCGCTCTTTGGCCGAGGTTATTCCCCTAG-3′/5′-ATGCTGCCGGCAAACCGCGCAGAACACTCATCTGATGCA-GAGCCGCGGGA-3′). Transformed bacteria were plated on negative selection plates containing glycerol and 2-deoxygalactose. Resulting colonies were again screened by PCR for the junction sequences as well as DNA sequence analysis. The desired BACs were further verified by BamH I digestion and Southern blot analysis. To reconstitute the mutant and revertant RacL11 BACs as standard virus, the BAC sequences were replaced with viral DNA sequences for the EUs4 gene by transfecting RK13 cells with both BAC and a plasmid containing the EUs4 sequences. Plaques lacking GFP expression were plaque purified for three rounds and then propagated to high titer on equine NBL-6 cells.
Southern, northern and western blot analyses
Mutant and revertant RacL11 BACs were subjected to BamH I digestion and then electrophoretically separated on a 0.6% agarose gel. Digested DNA was transferred onto a positively-charged nylon membrane (Ambion, Austin, TX) using a semi-dry electroblotter (Bio-Rad Laboratories, Hercules, CA). The transferred DNA was hybridized with a fragment of the UL4 gene (PCR product forward primer: 5′-GGCCTGGGCAGAGTTGGCTGCCTGCC-3′ and reverse primer: 5′-GCAGATCTTGCTCCCAGACCTGACC-3′) end-labeled with [γ-32 P]ATP (New England Nuclear Corporation, Boston, MA) by T4 polynucleotide kinase (Promega) in ULTRAhyb ultrasensitive hybridization buffer (Ambion). Free radio-labeled probe was washed away with 2× SSC/0.1% SDS followed by 0.1× SSC/0.1% SDS. A final wash with 2× SSC was completed before wrapping the membrane in plastic and exposing to a phosphor screen and scanning on the molecular imager FX system (Bio-Rad Laboratories). Northern blot analysis was performed by isolating total RNA from RK13 cells infected with RacL11 EHV-1 at the indicated times using the RNA-Bee RNA isolation reagent (AMS Biotechnology (Europe) Ltd, Abingdon, U.K.) per the manufacturer's procedure (Chomczynski and Sacchi, 1987) . RNA samples were separated on a 6% denaturing urea-polyacrylamide gel. The above procedures were followed for transferring and probing the RNA on the membranes. The probe used was a short fragment of the UL4 DNA (5′-TTATCGTT-TATTTTCTCGCTGGCGCTCTTTGGCCGAGGTTATTCCCCTAG-3′). Western blot analyses were performed using protein lysates from RK13 cells infected with virus or transfected with expression plasmids. The protein samples were separated on 10% SDS polyacrylamide gels and transferred to nitrocellulose membranes using the semi-dry electroblotter. Membranes were blocked with 1-5% dry milk in PBS/0.3% Tween-20 (PBST). Membranes were rinsed with PBST and incubated with EHV-1 specific primary antibodies, as indicated, followed by goat anti-rabbit or anti-mouse secondary antibody conjugated to alkaline phosphatase (Sigma, Saint Louis, MO). Protein-antibody complexes were visualized using the AP color reagent (Bio-Rad Laboratories) following the manufacturer's instructions.
Use of metabolic inhibitors
The procedure for virus infection with the use of metabolic inhibitors is described elsewhere (Gray et al., 1987) . To detect immediate early transcripts, cells were incubated in the presence of the protein synthesis inhibitor cycloheximide (CHX, 100 μg/mL; Sigma) for 30 min prior to infection with EHV-1. Cells were infected with wild-type EHV-1 (MOI of 10) and maintained in the presence of CHX for 4 h, at which time RNA was isolated. To distinguish early from late transcripts, cells were treated with phosphonoacetic acid (PAA, 100 μg/mL; Sigma) for 30 min prior to infection and then for 8 h after infection when RNA was isolated. The RNA was subjected to northern blot analysis as detailed above.
Growth kinetics, cell tropism and plaque morphology Cells were seeded into 60 mm dishes to 80% confluency and infected at an MOI of 5. Virus was harvested from the cells and supernatant at the indicated times post-infection and serially diluted to perform plaque assays on RK13 monolayers. Infected monolayers were incubated with medium containing 1.5% methylcellulose, and plaques were enumerated after three days by fixing with 10% formalin and staining with 0.5% methylene blue (Perdue et al., 1974) . Plaque morphology was examined using the ImageJ software (NIH, http://rsbweb.nih.gov/ij/).
Animal experiments and statistical analysis
Animal experiments were conducted as published previously (Osterrieder et al., 1996; von Einem et al., 2004) . Groups (n = 12) of 6 week-old female CBA mice were intranasally infected with 1.25 × 10 6 pfu of wild-type RacL11, UL4aa18stop, or ΔUL4R EHV-1 or mock-infected with sterile medium. Mice were weighed before infection and every day post-infection for 9 days to monitor changes in body weight. Mice were sacrificed at days 2, 3, and 4 post-infection, and whole lungs were harvested. Whole lungs were also isolated from animals that succumbed to virus infection. Lung tissue was disrupted using silica beads and BeadBeater (BioSpec Products, Inc., Bartlesville, OK), and virus was titered as described above. Statistical analysis was performed using the two-tailed Student's-t test to compare changes in body weight as well as mortality rates.
Gene expression in cells infected with wild-type and UL4aa18stop EHV-1 RK13 cells were infected with wild-type or UL4aa18stop EHV-1 to determine whether gene expression differs in the absence of the UL4P. RNA was isolated at 4, 8, and 12 hpi and examined by northern blot analysis using probes specific for the IE, TK and gK genes.
